Home > Insider Trading > Filing (0001127602-21-012027)

Filing Details

Accession Number:: 0001127602-21-012027
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-03-25 16:13:47
Reporting Period:: 2021-03-23

Accepted Time:: 2021-03-25 16:13:47
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1682852	Moderna Inc.	MRNA	Biological Products, (No Disgnostic Substances) (2836)	813467528

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1760669	Stephen Hoge	C/O Moderna, Inc. 200 Technology Square Cambridge MA 02139	President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-03-23	5,000	$10.90	1,614,597	No	4	M	Direct
Common Stock	Acquisiton	2021-03-23	10,000	$0.99	1,624,597	No	4	M	Direct
Common Stock	Disposition	2021-03-23	641	$136.96	1,623,956	No	4	S	Direct
Common Stock	Disposition	2021-03-23	2,139	$138.25	1,621,817	No	4	S	Direct
Common Stock	Disposition	2021-03-23	1,873	$139.19	1,619,944	No	4	S	Direct
Common Stock	Disposition	2021-03-23	1,702	$140.16	1,618,242	No	4	S	Direct
Common Stock	Disposition	2021-03-23	1,100	$141.22	1,617,142	No	4	S	Direct
Common Stock	Disposition	2021-03-23	859	$141.98	1,616,283	No	4	S	Direct
Common Stock	Disposition	2021-03-23	600	$143.44	1,615,683	No	4	S	Direct
Common Stock	Disposition	2021-03-23	286	$144.19	1,615,397	No	4	S	Direct
Common Stock	Disposition	2021-03-23	5,800	$145.50	1,609,597	No	4	S	Direct
Common Stock	Acquisiton	2021-03-24	5,000	$10.90	1,614,597	No	4	M	Direct
Common Stock	Disposition	2021-03-24	5,000	$137.07	1,609,597	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2021-03-23	10,000	$0.00	10,000	$0.99
Common Stock	Stock Option (Right to Buy)	Disposition	2021-03-23	5,000	$0.00	5,000	$10.90
Common Stock	Stock Option (Right to Buy)	Disposition	2021-03-24	5,000	$0.00	5,000	$10.90

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
557,431	2023-08-19	No	4	M	Direct
351,972	2026-02-23	No	4	M	Direct
346,972	2026-02-23	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,116	Indirect	By Valhalla, LLC
Common Stock	151,933	Indirect	By Trust

Footnotes

The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on January 7, 2021.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $136.49 to $137.37. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $137.64 to $138.64. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $138.67 to $139.64. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $139.68 to $140.68. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $140.77 to $141.73. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $141.78 to $142.51 Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $142.88 to $143.79. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $143.91 to $144.41. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $144.92 to $145.79. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
These shares are owned directly by a trust for the benefit of Dr. Hoge's spouse and children, of which his spouse is a trustee. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose.
This option is fully vested and exercisable.
25% of this option vested and became exercisable on February 23, 2017, with the remainder vesting in 12 equal quarterly installments thereafter.